Occlutech
  • Occluders
    • Products
      • PFO
      • ASD
      • UNI
      • PDA
      • PLD
      • mVSD
      • PmVSD
      • Accessories
    • Live Cases
    • Publications
  • AFR
    • AFR
    • Accessories
    • Medical Rationale
      • Heart Failure
      • Pulmonary Arterial Hypertension*
    • Live Cases
    • Publications
    • Clinical Trials
  • For Patients
    • Anatomy of the heart
    • PFO
    • ASD
    • PDA
    • AFR
      • Heart Failure
      • Pulmonary Arterial Hypertension
  • News and Events
    • News
    • Events
  • About
    • About Occlutech
    • History
    • Careers
    • Management and Board
    • Charity
  • Contact
Menu
  • Occluders
    • Products
      • PFO
      • ASD
      • UNI
      • PDA
      • PLD
      • mVSD
      • PmVSD
      • Accessories
    • Live Cases
    • Publications
  • AFR
    • AFR
    • Accessories
    • Medical Rationale
      • Heart Failure
      • Pulmonary Arterial Hypertension*
    • Live Cases
    • Publications
    • Clinical Trials
  • For Patients
    • Anatomy of the heart
    • PFO
    • ASD
    • PDA
    • AFR
      • Heart Failure
      • Pulmonary Arterial Hypertension
  • News and Events
    • News
    • Events
  • About
    • About Occlutech
    • History
    • Careers
    • Management and Board
    • Charity
  • Contact

Clinical Trials AFR

The Atrial Flow Regulator is being evaluated for heart failure patients in two ongoing clinical studies (PRELIEVE and PROLONGER) and a prospective registry (AFteR), and in an ongoing clinical study for pulmonary arterial hypertension patients (PROPHET). Additional clinical studies are also being planned.

Heart Failure

PRELIEVE Study
Currently enrolling patients in a multicenter Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure Patients

PROLONGER Study
Currently enrolling patients in a multicenter study to assess invasive and non-invasive parameters that may predict clinical improvement in patients with congestive heart failure after implantation of the Atrial flow regulator (AFR) device 

AFteR Registry
Currently enrolling patients in a multicenter registry to monitor the safety and effectiveness of the Atrial Flow Regulator (AFR) device in patients with heart failure

Pulmonary Arterial Hypertension

PROPHET Study
Currently enrolling patients in a multicenter Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Patients with Pulmonary Hypertension 

Occluders

  • Products
  • - PFO
  • - ASD
  • - UNI
  • - PDA
  • - PLD
  • - mVSD
  • - PmVSD
  • - Accessories
  • Live Cases
  • Publications

AFR

  • AFR
  • - Accessories
  • Medical Rationale
  • - Heart Failure
  • - Pulmonary Hypertension
  • Live Cases
  • Publications
  • Clinical Trials

For Patients

  • Anatomy of the Heart
  • PFO
  • ASD
  • PDA
  • AFR
  • - Heart Failure
  • - Pulmonary Arterial Hypertension

News and Events

  • News
  • Events

About

  • Overview
  • History
  • Career
  • Management and Board
  • Charity

Contact

  • Contact
Occlutech

Occlutech International AB
Landskronavägen 2
SE-252 32 Helsingborg, Sweden
info@occlutech.com

Perfecting Performance

Terms and Conditions   Privacy Policy   Copyright Notice
Individual product availability subject to local regulatory clearance, may not be available in all territories.

© Occlutech 2018. All rights reserved. Occlutech is a registered trademark.

We use cookies to customize content for your viewing and for analytics. If you continue to browse this website, we will assume that you are happy to receive all our cookies. Learn more

got it